INGENIO J172

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2018-10-25 for INGENIO J172 manufactured by Boston Scientific Corporation.

Event Text Entries

[125033244] An investigation into this event is currently ongoing.
Patient Sequence No: 1, Text Type: N, H10


[125033245] It was reported that this pacemaker oversensed noise resulting in pacing inhibition with asystole for more than two seconds. The patient is pacemaker dependent patient and was syncopal. The patient was prescribed a holter monitor which confirmed frequent instances of noise with pacing inhibition. Isometrics and pocket manipulation were successfully in recreating noise. The device was reprogrammed and intervention is likely.
Patient Sequence No: 1, Text Type: D, B5


[131952437] The product has been received for analysis. This report will be updated upon completion of analysis.
Patient Sequence No: 1, Text Type: N, H10


[131952438] It was reported that this pacemaker oversensed noise resulting in pacing inhibition with asystole for more than two seconds. The patient is pacemaker dependent patient and was syncopal. The patient was prescribed a holter monitor which confirmed frequent instances of noise with pacing inhibition. Isometrics and pocket manipulation were successfully in recreating noise. The device was reprogrammed and intervention is likely. The device was explanted.
Patient Sequence No: 1, Text Type: D, B5


[140202582] Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the device was performed. A visual inspection of the device header and case noted no anomalies. Pin gauge testing, designed to verify proper port dimensions, was completed. Each port measured as expected. The device was then exposed to simulated heart load conditions, and the pacing, and sensing functions were tested. Impedance testing was completed and all measurements were within normal limits. The device operated appropriately with no interruptions in therapy output at the returned programmed settings. A series of electrical tests was also performed, and again, normal device function was observed.
Patient Sequence No: 1, Text Type: N, H10


[140202584] It was reported that this pacemaker oversensed noise resulting in pacing inhibition with asystole for more than two seconds. The patient is pacemaker dependent patient and was syncopal. The patient was prescribed a holter monitor which confirmed frequent instances of noise with pacing inhibition. Isometrics and pocket manipulation were successfully in recreating noise. The device was reprogrammed and intervention is likely. The device was explanted.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2124215-2018-60066
MDR Report Key8006187
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2018-10-25
Date of Report2019-01-03
Date of Event2017-11-01
Date Mfgr Received2018-10-15
Device Manufacturer Date2013-01-30
Date Added to Maude2018-10-25
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactTIMOTHY DEGROOT
Manufacturer Street4100 HAMLINE AVENUE NORTH ,
Manufacturer CitySAINT PAUL MN 55112
Manufacturer CountryUS
Manufacturer Postal55112
Manufacturer Phone6515826168
Manufacturer G1BOSTON SCIENTIFIC CLONMEL LIMITED
Manufacturer StreetCASHEL ROAD ,
Manufacturer CityCLONMEL
Manufacturer CountryEI
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameINGENIO
Generic NamePULSE-GENERATOR, SINGLE CHAMBER, SINGLE
Product CodeLWW
Date Received2018-10-25
Returned To Mfg2018-11-12
Model NumberJ172
Catalog NumberJ172
Lot Number104137
Device Expiration Date2015-01-24
OperatorLAY USER/PATIENT
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerBOSTON SCIENTIFIC CORPORATION
Manufacturer Address4100 HAMLINE AVENUE NORTH , SAINT PAUL MN 55112 US 55112


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Life Threatening; 3. Required No Informationntervention 2018-10-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.